Aberrant P-bodies accumulation and clearance in yeast and human cells.
酵母和人体细胞中异常 P 体的积累和清除。
基本信息
- 批准号:10390634
- 负责人:
- 金额:$ 23.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-18 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAutophagocytosisBehaviorBiologicalBiological ModelsBrainCaringCell LineCell SurvivalCell modelCell physiologyCellsChildCytoplasmic GranulesDataDefectDevelopmentDiseaseEconomic BurdenEnzymesEtiologyFamilyFibroblastsGenesGoalsGrowthHumanIndividualIntellectual functioning disabilityKnowledgeLeadLiquid substanceLysosomesMembraneMessenger RNAMissense MutationMissionModelingMolecular GeneticsMutationNational Institute of Neurological Disorders and StrokeNeuritesNeurodevelopmental DisorderNeuronsNonsense-Mediated DecayOrganellesPathogenicityPathway interactionsPatientsPhasePhenotypePlayPopulationPredispositionProteinsRNARNA ProcessingRNA helicase ARegulationResearchRoleSeveritiesSocietiesStressSynaptic plasticitySystemToxic effectTransfectionUbiquitinVariantYeastsbasecell growthcell immortalizationcell motilityde novo mutationearly onsetgenome sequencinghelicasehuman diseasehuman tissueinsightmRNA Decaymulticatalytic endopeptidase complexmutantnovelnovel therapeutic interventionresponsesevere intellectual disabilitytissue/cell cultureyeast protein
项目摘要
Abstract
RNA-protein (RNP) granules are dynamic membrane-less organelles that form during normal
growth and in response to stress in a reversible manner. One type of RNP granules is
Processing Bodies (P-bodies, or PBs), which contain mRNA together with RNA processing
enzymes. Their roles include sequestration of malfunctioning mRNA destined for degradation
and storing and silencing of mRNAs when not needed. PBs components and behavior are
highly conserved between yeast and human cells. Our understanding of composition and
assembly by liquid-phase separation normal PBs has progressed in the last decade. In contrast,
our knowledge about involvement of PBs in human disease is scarce as is evidence about the
occurrence of aberrant PBs and clearance of normal or aberrant PBS.
In this project, we propose to study variants in a PBs component associated with a
neurodevelopmental disorder that causes intellectual disability. Currently, there is no cure for
such disorders. We hypothesize that the variants cause accumulation of aberrant PBs that,
unlike normal PBs, are not reversible. The human variants carry missense mutations in residues
identical in the yeast protein. Therefore, we started by modeling the effects of these mutations
on RNA processing and accumulation of PBs in yeast. While normal PBs assemble and
disassemble according to cellular needs, our preliminary evidence in yeast cells points to
accumulation of persistent PBs as the major phenotype of these mutations. We propose to
study the effects of these mutations in yeast and in human tissue culture cells, including
neuronal cell lines. The phenotypes we propose to assess are on the accumulation and
dynamics of persistent PBs, including adverse effects they might have on cell function. In
addition, we will explore possible pathways that can clear normal and persistent PBs, such as
macro- and micro-autophagy and ubiquitin-associated degradation. For these studies we will
use a combination of molecular genetics and cellular approaches. Most approaches for studying
RNP granules, granule clearance pathways in yeast and human cells are established in our lab.
Achieving the goals of this proposal would provide novel paradigms on existence and behavior
of persistent PBs and the role they play in a neurodevelopmental disorder. Moreover, identifying
pathways that can clear normal and aberrant PBs would provide novel therapeutic strategies for
a neurodevelopmental disorder associated with intellectual disability, in line with the missions of
the National Institute of Neurological Disorders and Stroke.
抽象的
RNA 蛋白 (RNP) 颗粒是在正常情况下形成的动态无膜细胞器。
生长和以可逆的方式应对压力。一种类型的 RNP 颗粒是
加工体(P-体,或 PB),包含 mRNA 和 RNA 加工
酶。它们的作用包括隔离注定要降解的故障 mRNA
不需要时存储和沉默 mRNA。 PB 组件和行为是
在酵母和人类细胞之间高度保守。我们对构图的理解和
通过液相分离普通PB的组装在过去十年中取得了进展。相比之下,
我们对 PB 与人类疾病的关系知之甚少,关于 PB 参与人类疾病的证据也是如此。
异常 PB 的发生以及正常或异常 PBS 的清除。
在这个项目中,我们建议研究与
导致智力障碍的神经发育障碍。目前尚无治愈方法
此类疾病。我们假设这些变异会导致异常 PB 的积累,
与普通 PB 不同,它们是不可逆的。人类变异体在残基中携带错义突变
与酵母蛋白相同。因此,我们首先对这些突变的影响进行建模
酵母中 RNA 加工和 PB 积累的影响。虽然普通 PB 会组装并
根据细胞需要进行拆卸,我们在酵母细胞中的初步证据表明
持久性 PB 的积累是这些突变的主要表型。我们建议
研究这些突变对酵母和人体组织培养细胞的影响,包括
神经元细胞系。我们建议评估的表型是积累和
持久性 PB 的动态,包括它们可能对细胞功能产生的不利影响。在
此外,我们将探索清除正常和持续性PB的可能途径,例如
宏观和微观自噬以及泛素相关降解。对于这些研究,我们将
结合使用分子遗传学和细胞方法。大多数学习方法
我们的实验室建立了 RNP 颗粒、酵母和人体细胞中的颗粒清除途径。
实现该提案的目标将为存在和行为提供新颖的范式
持续性 PB 及其在神经发育障碍中的作用。此外,识别
清除正常和异常 PB 的途径将为以下疾病提供新的治疗策略:
与智力障碍相关的神经发育障碍,符合
国家神经疾病和中风研究所。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nava Segev其他文献
Nava Segev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nava Segev', 18)}}的其他基金
Aberrant P-bodies accumulation and clearance in yeast and human cells.
酵母和人体细胞中异常 P 体的积累和清除。
- 批准号:
10551880 - 财政年份:2022
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10832932 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10581959 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10798944 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10704918 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10615724 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10197424 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Coordination of intracellular trafficking pathways by Ypt/Rab GTPases and their GEFs.
Ypt/Rab GTPases 及其 GEF 协调细胞内运输途径。
- 批准号:
10399615 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
The role of Rab1 GTPase and its activators in selective autophagy and neurodegenerative disease
Rab1 GTPase 及其激活剂在选择性自噬和神经退行性疾病中的作用
- 批准号:
9225579 - 财政年份:2016
- 资助金额:
$ 23.99万 - 项目类别:
ROLE OF YPT GTPASES IN INTRACELLULAR TRAFFICKING
YPT GTASE 在细胞内贩运中的作用
- 批准号:
7957793 - 财政年份:2009
- 资助金额:
$ 23.99万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 23.99万 - 项目类别:
Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences.
COVID-19 大流行期间疗养院的探视禁令:有效性和后果。
- 批准号:
10635829 - 财政年份:2023
- 资助金额:
$ 23.99万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 23.99万 - 项目类别:
Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault.
开发一种针对焦虑敏感性的数字疗法,以减少性侵犯后寻求紧急护理的女性的 PTSD-SUD。
- 批准号:
10449766 - 财政年份:2023
- 资助金额:
$ 23.99万 - 项目类别: